BSX
Price
$105.38
Change
+$0.46 (+0.44%)
Updated
Aug 1, 04:26 PM (EDT)
Capitalization
100.1B
82 days until earnings call
PODD
Price
$285.09
Change
-$3.31 (-1.15%)
Updated
Aug 1, 04:50 PM (EDT)
Capitalization
11.75B
6 days until earnings call
Interact to see
Advertisement

BSX vs PODD

Header iconBSX vs PODD Comparison
Open Charts BSX vs PODDBanner chart's image
Boston Scientific
Price$105.38
Change+$0.46 (+0.44%)
Volume$11.28K
Capitalization100.1B
Insulet
Price$285.09
Change-$3.31 (-1.15%)
Volume$1.32K
Capitalization11.75B
BSX vs PODD Comparison Chart in %
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. PODD commentary
Aug 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Buy and PODD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 01, 2025
Stock price -- (BSX: $104.92 vs. PODD: $288.48)
Brand notoriety: BSX: Notable vs. PODD: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 85% vs. PODD: 90%
Market capitalization -- BSX: $100.1B vs. PODD: $11.75B
BSX [@Medical Specialties] is valued at $100.1B. PODD’s [@Medical Specialties] market capitalization is $11.75B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whilePODD’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • PODD’s FA Score: 1 green, 4 red.
According to our system of comparison, BSX is a better buy in the long-term than PODD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 6 TA indicator(s) are bullish while PODD’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 6 bullish, 3 bearish.
  • PODD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BSX is a better buy in the short-term than PODD.

Price Growth

BSX (@Medical Specialties) experienced а -1.21% price change this week, while PODD (@Medical Specialties) price change was +0.66% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.83%. For the same industry, the average monthly price growth was -2.41%, and the average quarterly price growth was -4.87%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

PODD is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical Specialties (-2.83% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than PODD($11.8B). BSX has higher P/E ratio than PODD: BSX (63.64) vs PODD (57.17). BSX YTD gains are higher at: 17.465 vs. PODD (10.499). BSX has higher annual earnings (EBITDA): 3.45B vs. PODD (324M). BSX has more cash in the bank: 865M vs. PODD (704M). PODD has less debt than BSX: PODD (1.42B) vs BSX (9.49B). BSX has higher revenues than PODD: BSX (14.2B) vs PODD (1.7B).
BSXPODDBSX / PODD
Capitalization100B11.8B847%
EBITDA3.45B324M1,064%
Gain YTD17.46510.499166%
P/E Ratio63.6457.17111%
Revenue14.2B1.7B837%
Total Cash865M704M123%
Total Debt9.49B1.42B670%
FUNDAMENTALS RATINGS
BSX vs PODD: Fundamental Ratings
BSX
PODD
OUTLOOK RATING
1..100
6757
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
468
SMR RATING
1..100
6925
PRICE GROWTH RATING
1..100
4946
P/E GROWTH RATING
1..100
4363
SEASONALITY SCORE
1..100
16n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSX's Valuation (85) in the Medical Specialties industry is in the same range as PODD (89). This means that BSX’s stock grew similarly to PODD’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is somewhat better than the same rating for PODD (68). This means that BSX’s stock grew somewhat faster than PODD’s over the last 12 months.

PODD's SMR Rating (25) in the Medical Specialties industry is somewhat better than the same rating for BSX (69). This means that PODD’s stock grew somewhat faster than BSX’s over the last 12 months.

PODD's Price Growth Rating (46) in the Medical Specialties industry is in the same range as BSX (49). This means that PODD’s stock grew similarly to BSX’s over the last 12 months.

BSX's P/E Growth Rating (43) in the Medical Specialties industry is in the same range as PODD (63). This means that BSX’s stock grew similarly to PODD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXPODD
RSI
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 5 days ago
45%
Bearish Trend 17 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PNF6.740.01
+0.15%
PIMCO NEW YORK Municipal Income FUND
MYMI24.33N/A
N/A
SPDR SSGA My2029 Municipal Bond ETF
CATH76.99-0.34
-0.44%
Global X S&P 500® Catholic Values ETF
VALQ61.38-0.77
-1.24%
American Century® U.S. Quality Value ETF
BMED24.71-0.58
-2.28%
iShares Health Innovation Active ETF

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-1.72%
ISRG - BSX
71%
Closely correlated
-3.88%
SYK - BSX
69%
Closely correlated
-1.92%
MMSI - BSX
58%
Loosely correlated
+2.29%
ALC - BSX
48%
Loosely correlated
-1.83%
AORT - BSX
46%
Loosely correlated
-2.09%
More

PODD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
-3.28%
ISRG - PODD
48%
Loosely correlated
-3.88%
BSX - PODD
44%
Loosely correlated
-1.72%
SYK - PODD
40%
Loosely correlated
-1.92%
MMSI - PODD
37%
Loosely correlated
+2.29%
PEN - PODD
36%
Loosely correlated
-0.76%
More